EQT Fund Management S.a r.l.
CIK 1834239
13F filing for Q2 2026・No. 2,829
- Holdings
- US$862.62M
- Quarter change
- −US$158.13M
- Entries
- 5
- Net bought (estimate)
- +US$19.33M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 0
- Sold out 0
- Cut 0
- Added 2
- Corporate actions 0
- Unchanged 3
Largest holdings
5 stocks worth US$862.62M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| WAYWAYSTAR HLDG CORPCOM | Unchanged | 24,879,437 | US$510.77M | 59.21% |
| PHARVARIS N VCOM | Unchanged | 3,424,609 | US$118.42M | 13.73% |
| OCULIS HOLDING AGORDINARY SHARES | Added | 6,950,294 | US$96.4M | 11.18% |
| EVOMMUNE INCCOM SHS | Added | 5,288,313 | US$70.28M | 8.15% |
| AGOMAB THERAPEUTICS NVSPONSORED ADS | Unchanged | 5,141,992 | US$66.74M | 7.74% |
Sign in (free) to see its 5 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 13, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.